Literature DB >> 20187065

Neoadjuvant strategies for the treatment of locally advanced esophageal cancer.

John R Hyngstrom1, Mitchell C Posner.   

Abstract

Patients with locally advanced esophageal carcinoma have consistently poor survival following surgery with associated high systemic and local-regional failure rates. Neoadjuvant therapeutic strategies have been employed in an attempt to improve outcome with variable success. Randomized trials of either neoadjuvant chemotherapy or chemoradiotherapy have shown conflicting results regarding survival and local-regional control. Future efforts should focus on identifying novel agents and targets to improve therapeutic efficacy.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20187065     DOI： 10.1002/jso.21479

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  12 in total

1.  MicroRNAs and esophageal cancer.

Authors:  Santosh Kumar Patnaik; Reema Mallick; Sai Yendamuri
Journal:  J Gastrointest Oncol       Date:  2010-09

2.  Esophageal stent fixation with endoscopic suturing device improves clinical outcomes and reduces complications in patients with locally advanced esophageal cancer prior to neoadjuvant therapy: a large multicenter experience.

Authors:  Juliana Yang; Ali A Siddiqui; Thomas E Kowalski; David E Loren; Ammara Khalid; Ayesha Soomro; Syed M Mazhar; Julian Rosé; Laura Isby; Michel Kahaleh; Ankush Kalra; Alex M Sarkisian; Nikhil A Kumta; Jose Nieto; Reem Z Sharaiha
Journal:  Surg Endosc       Date:  2016-08-05       Impact factor: 4.584

3.  Prognostic implications of lymphadenectomy in esophageal cancer after neo-adjuvant therapy: a single center experience.

Authors:  Zachary Torgersen; Abhishek Sundaram; Masato Hoshino; Brittany Willer; Xiang Fang; Tsewang Tashi; Tommy Lee; Sumeet K Mittal
Journal:  J Gastrointest Surg       Date:  2011-08-02       Impact factor: 3.452

4.  Postoperative survival following perioperative MAGIC versus neoadjuvant OE02-type chemotherapy in oesophageal adenocarcinoma.

Authors:  A M Reece-Smith; J H Saunders; I N Soomro; C R Bowman; J P Duffy; P V Kaye; N T Welch; S Madhusudan; S L Parsons
Journal:  Ann R Coll Surg Engl       Date:  2017-05       Impact factor: 1.891

Review 5.  The value of epigenetic markers in esophageal cancer.

Authors:  Xiao-Mei Zhang; Ming-Zhou Guo
Journal:  Front Med China       Date:  2010-11-24

6.  CXCR7 expression in esophageal cancer.

Authors:  Michael Tachezy; Hilke Zander; Florian Gebauer; Katharina von Loga; Klaus Pantel; Jakob R Izbicki; Maximilian Bockhorn
Journal:  J Transl Med       Date:  2013-09-30       Impact factor: 5.531

7.  Survival after neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta-analysis.

Authors:  Mengying Fan; Yao Lin; Jianhong Pan; Wanpu Yan; Liang Dai; Luyan Shen; Keneng Chen
Journal:  Thorac Cancer       Date:  2015-08-11       Impact factor: 3.500

8.  Is there a role of whole-body bone scan in patients with esophageal squamous cell carcinoma.

Authors:  Shau-Hsuan Li; Yung-Cheng Huang; Wan-Ting Huang; Wei-Che Lin; Chien-Ting Liu; Wan-Yu Tien; Hung-I Lu
Journal:  BMC Cancer       Date:  2012-08-01       Impact factor: 4.430

9.  The predictive value of histological tumor regression grading (TRG) for therapeutic evaluation in locally advanced esophageal carcinoma treated with neoadjuvant chemotherapy.

Authors:  Kang Guo; Ling Cai; Yu Zhang; Jian-Fei Zhu; Tie-Hua Rong; Peng Lin; Chong-Li Hao; Wu-Ping Wang; Zhe Li; Lan-Jun Zhang
Journal:  Chin J Cancer       Date:  2012-05-08

10.  Role of barium esophagography in patients with locally advanced esophageal cancer: evaluation of response to neoadjuvant chemoradiotherapy.

Authors:  Daisuke Tsurumaru; Kiyohisa Hiraka; Masahiro Komori; Yoshiyuki Shioyama; Masaru Morita; Hiroshi Honda
Journal:  Radiol Res Pract       Date:  2013-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.